Search
Close this search box.

PRP – Platelet-Rich Plasma or Ovarian Rejuvenation

Ovarian and Endometrium Rejuvenation may be used for Patients with Low Ovarian Reserve or Recurrent Implantation Failure.

One of the most intriguing developments in fertility therapy in recent years is the use of PRP, which is still a relatively new procedure. That said, it may be able to address some of the most typical obstacles to a healthy pregnancy.

Ovarian rejuvenation or Platelet Rich Plasma (PRP) treatment is a procedure that utilizes the patient’s own blood to isolate the platelet-rich plasma (PRP) which contains stem cells and other growth factors.

In recent years, Platelet-Rich Plasma (PRP) has been used in conjunction with traditional fertility treatments like In Vitro Fertilization (IVF) to increase the quality of eggs, the thickness of the uterine lining, and the receptivity of the endometrium, mainly in the treatment of persistent implantation failure experienced over several IVF cycles. Although the treatment still needs additional scientific literature to demonstrate and thoroughly support its general efficacy, it is becoming more and more popular due to its positive clinical outcomes.

PRP is used in several reproductive procedures, such as IUI and IVF, to help with and improve egg quantity and quality as well as to increase the thickness of the uterine lining and increase endometrial receptivity during embryo transfer.

It is most frequently utilized in patients with a history of recurrent implantation failure (RIF), a condition when numerous IVF transfers fail to result in pregnancy even if high-quality embryos were used each time. Prior to employing donor egg IVF, PRP is often tested; however, it may also be used in conjunction with donor egg cycles and other supportive therapies concentrating on reproductive immunology.

AFCT Testimonial for PRP Therapy

“If you do not push the boundaries, you will never know where they are.” – T. S. Eliot.

Working with only one ovary and quite a bit of scar tissue from previous endometriosis surgeries, we went into this journey with realistic expectations. After getting no viable embryos in the first round and only one in the second round, we were disappointed, but knew we weren’t done trying quite yet. We were pleasantly surprised when Dr. Allon suggested we try two rounds of Ovarian Rejuvenation injections before our third round to help give us the boost we may need.

We were familiar with PRP in athletic and orthopedic medicine, but we hadn’t come across it in any of our fertility research. The science made sense though and we decided to give it a shot. The proof that it worked came earlier than expected though because while waiting to start our third round of IVF, mother nature decided to take the matter into her own hands. Sitting here now with our beautiful healthy daughter, Ainsley Jo, and we know we chose the right people for the job.

Thanks to Dr. Allon, Amy, and all the staff at Advanced Fertility Center our family has a new bundle of joy and a renewed hope for more in the future. Their willingness to stay at the forefront of fertility medicine and do whatever is necessary to see their clients through to the finish line is inspiring and we couldn’t have asked for better guides in this adventure.

– The Garner Family

Scientific Research

Luteinizing hormone–independent rise of progesterone as the physiological trigger of the ovulatory gonadotropins surge in the human

Fertility and Sterility
Click to zoom image

Recipient outcomes in an oocyte donation programme: should very young donors be excluded?

RBMO Oocyte Donation Programme
Click to zoom image